NO20083506L - Beta-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette - Google Patents

Beta-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette

Info

Publication number
NO20083506L
NO20083506L NO20083506A NO20083506A NO20083506L NO 20083506 L NO20083506 L NO 20083506L NO 20083506 A NO20083506 A NO 20083506A NO 20083506 A NO20083506 A NO 20083506A NO 20083506 L NO20083506 L NO 20083506L
Authority
NO
Norway
Prior art keywords
crystalline form
arginine salt
preparation
perindopril
beta
Prior art date
Application number
NO20083506A
Other languages
English (en)
Other versions
NO341238B1 (no
Inventor
Gerard Coquerel
Loic Lefebvre
Jean-Claude Souvie
Pascale Authouart
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20083506L publication Critical patent/NO20083506L/no
Publication of NO341238B1 publication Critical patent/NO341238B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

?-KRYSTALLINSK FORM AV ARGININSALTET TIL PERINDOPRIL, EN PROSESS FOR DETS FREMSTILLING OG FARMASØYTISKE SAMMENSETNINGER INNEHOLDENDE DETTE Den ß-krystallinske formen til forbindelsen ifølge formel (I): karakterisert ved dens pulver røntgendiffraksjonsdiagram. Medikamenter.
NO20083506A 2006-02-28 2008-08-13 Beta-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasøytiske sammensetninger inneholdende dette NO341238B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601747A FR2897865B1 (fr) 2006-02-28 2006-02-28 Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
PCT/FR2007/000334 WO2007099216A2 (fr) 2006-02-28 2007-02-26 FORME CRISTALLINE β DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (2)

Publication Number Publication Date
NO20083506L true NO20083506L (no) 2008-08-13
NO341238B1 NO341238B1 (no) 2017-09-25

Family

ID=37198804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083506A NO341238B1 (no) 2006-02-28 2008-08-13 Beta-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasøytiske sammensetninger inneholdende dette

Country Status (30)

Country Link
US (1) US7923569B2 (no)
EP (1) EP2016051B1 (no)
JP (1) JP5611524B2 (no)
KR (1) KR20080106947A (no)
CN (1) CN101389604B (no)
AT (1) ATE465992T1 (no)
AU (1) AU2007220434B2 (no)
BR (1) BRPI0708291B8 (no)
CA (1) CA2643803C (no)
CY (1) CY1110082T1 (no)
DE (1) DE602007006176D1 (no)
DK (1) DK2016051T3 (no)
EA (1) EA014715B1 (no)
ES (1) ES2345291T3 (no)
FR (1) FR2897865B1 (no)
GE (1) GEP20135839B (no)
HR (1) HRP20100357T1 (no)
MA (1) MA30277B1 (no)
ME (1) ME01805B (no)
MX (1) MX2008010747A (no)
MY (1) MY143557A (no)
NO (1) NO341238B1 (no)
NZ (1) NZ570366A (no)
PL (1) PL2016051T3 (no)
PT (1) PT2016051E (no)
RS (1) RS51431B (no)
SI (1) SI2016051T1 (no)
UA (1) UA89904C2 (no)
WO (1) WO2007099216A2 (no)
ZA (1) ZA200807025B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2897866B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
AU2013245523C1 (en) * 2008-06-24 2017-09-07 Tianish Laboratories Private Limited Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof
AU2009263737B2 (en) * 2008-06-24 2013-10-24 Tianish Laboratories Private Limited Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril

Also Published As

Publication number Publication date
US20090186934A1 (en) 2009-07-23
CA2643803C (fr) 2017-08-08
CY1110082T1 (el) 2015-01-14
DK2016051T3 (da) 2010-08-09
CN101389604B (zh) 2013-08-21
RS51431B (sr) 2011-04-30
NO341238B1 (no) 2017-09-25
AU2007220434A1 (en) 2007-09-07
GEP20135839B (en) 2013-06-10
MX2008010747A (es) 2008-09-01
PT2016051E (pt) 2010-05-13
HRP20100357T1 (hr) 2010-07-31
JP5611524B2 (ja) 2014-10-22
CA2643803A1 (fr) 2007-09-07
JP2009529500A (ja) 2009-08-20
NZ570366A (en) 2011-05-27
WO2007099216A2 (fr) 2007-09-07
ZA200807025B (en) 2009-11-25
CN101389604A (zh) 2009-03-18
SI2016051T1 (sl) 2010-07-30
ES2345291T3 (es) 2010-09-20
HK1129668A1 (en) 2009-12-04
EA014715B1 (ru) 2011-02-28
ATE465992T1 (de) 2010-05-15
EP2016051A2 (fr) 2009-01-21
BRPI0708291A2 (pt) 2011-05-24
BRPI0708291B8 (pt) 2021-05-25
AU2007220434B2 (en) 2010-10-14
MA30277B1 (fr) 2009-03-02
EP2016051B1 (fr) 2010-04-28
DE602007006176D1 (de) 2010-06-10
EA200801772A1 (ru) 2009-02-27
ME01805B (me) 2011-04-30
UA89904C2 (ru) 2010-03-10
FR2897865A1 (fr) 2007-08-31
PL2016051T3 (pl) 2010-08-31
KR20080106947A (ko) 2008-12-09
WO2007099216A3 (fr) 2007-10-25
FR2897865B1 (fr) 2008-04-18
MY143557A (en) 2011-05-31
US7923569B2 (en) 2011-04-12
BRPI0708291B1 (pt) 2021-02-02

Similar Documents

Publication Publication Date Title
NO20083506L (no) Beta-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette
AR034124A1 (es) Forma cristalina alfa de la sal de terbutilamina de perindopril, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
EA200802119A1 (ru) Новая кристаллическая форма vi агомелатина, способ его получения и фармацевтические композиции, которые ее содержат
TW200740761A (en) Histone deacetylase inhibitors
TW200736198A (en) New crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
EA200601273A1 (ru) Новая кристаллическая форма v агомелатина, способ её получения и фармацевтические композиции, которые её содержат
TW200716511A (en) New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
MX2009005616A (es) Derivados de pirido-pirazina utiles como compuestos herbicidas.
EA200601274A1 (ru) Новая кристаллическая форма iii агомелатина, способ её получения и фармацевтические композиции, которые её содержат
GEP20125433B (en) α CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT
WO2009039362A3 (en) Chiral synthesis of diazepinoquinolines
MD4350B1 (ro) Forma cristalină delta a sării de L-arginină a perindoprilului, procedeu de obţinere a ei şi compoziţii farmaceutice care o conţin
EA200900936A1 (ru) Аморфные и кристаллические формы ривастигмина гидротартрата
EA200800464A1 (ru) Фармацевтическая композиция, содержащая периндоприл или его соли
RU2011146144A (ru) Новые стабильные кристаллы моногидрохлорида 1-(2'-дезокси-бета-d-арабинофуранозил)цитозина
MX2008002064A (es) Un proceso para la preparacion de perindopril-erbumina.
EA200971031A1 (ru) Моногидрохлориды ингибитора гистондеацетилазы
TNSN05076A1 (en) New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
WO2006133322A3 (en) Synthesis of 3-amino-4-substituted pyrazole derivatives
WO2006082598A3 (en) Novel crystalline forms of rizatriptan benzoate
TNSN05077A1 (en) New y crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
GEP20094652B (en) New cyrstalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it
LV14275A (lv) Ar bis-triazolu tiltiņu saistītu disaharīdu sintēze
TH88291B (th) ผลึกรูปแบบ iv ชนิดใหม่ของอะโกเมลาทีน, กรรมวิธีในการเตรียมและองค์ประกอบทางเภสัชกรรมซึ่งมีสารนี้